D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1

Carcinogenesis

Volumn 28, Issue 1, 2007, Pages 151-162

  Choi, Sunga ^a   Lew, Karen L ^a   Xiao, Hui ^a   Herman Antosiewicz, Anna ^a   Xiao, Dong ^a   Brown, Charles K ^a   Singh, Shivendra V ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SULFORAPHANE; SYNAPTOTAGMIN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; WILD TYPE;

ANTICARCINOGENIC AGENTS; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL LINE, TUMOR; E2F1 TRANSCRIPTION FACTOR; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; KINETICS; MALE; NF-KAPPA B; PROSTATIC NEOPLASMS; PROTEIN CONFORMATION; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; THIOCYANATES; TUMOR SUPPRESSOR PROTEIN P53; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 33845623882     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl144     Document Type: Article

References (52)

1. Verhoeven,D.T., Goldbohm,R.A., van Poppel,G., Verhagen,H. and van den Brandt,P.A. (1996) Epidemiological studies on Brassica vegetables and cancer risk. Cancer Epidemiol. Biomarkers Prev., 5, 733-748.
2. Cohen,J.H., Kristal,A.R. and Stanford,J.L. (2000) Fruit and vegetable intakes and prostate cancer risk. J. Natl Cancer. Inst., 92, 61-68.
3. Zhang,S.M., Hunter,D.J., Rosner,B.A., Giovannucci,E.L., Colditz,G.A., Speizer,F.E. and Willett,W.C. (2000) Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin's lymphoma among women. Cancer Epidemiol. Biomarkers Prev., 9, 477-485.
4. Ambrosone,C.B., McCann,S.E., Freudenheim,J.L., Marshall,J.R., Zhang,Y. and Shields,P.G. (2004) Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. J. Nutr., 134, 1134-1138.
5. Hecht,S.S. (2000) Inhibition of carcinogenesis by isothiocyanates. Drug Metab. Rev., 32, 395-411.
6. Talalay,P. and Fahey,J.W. (2001) Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J. Nutr., 131 ((suppl.)), 3027s-3033s.
7. Fahey,J.W., Zalcmann,A.T. and Talalay,P. (2001) The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry, 56, 5-51.
8. Zhang,Y., Talalay,P., Cho,C.G. and Posner,G.H. (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure. Proc. Natl Acad. Sci. USA, 89, 2399-2403.
9. Brooks,J.D., Paton,V.G. and Vidanes,G. (2001) Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol. Biomarkers Prev., 10, 949-954.
10. Barcelo,S., Gardiner,J.M., Gescher,A. and Chipman,J.K. (1996) CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis, 17, 277-282.
11. Zhang,Y., Kensler,T.W., Cho,C.G., Posner,G.H. and Talalay,P. (1994) Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl Acad. Sci. USA, 91, 3147-3150.
12. Fahey,J.W., Zhang,Y. and Talalay,P. (1997) Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl Acad. Sci. USA, 94, 10367-10372.
13. Chung,F.L., Conaway,C.C., Rao,C.V. and Reddy,B.S. (2000) Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis, 21, 2287-2291.
14. Fahey,J.W., Haristoy,X., Dolan,P.M., Kensler,T.W., Scholtus,I., Stephenson,K.K., Talalay,P. and Lozniewski,A. (2002) Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc. Natl Acad. Sci. USA, 99, 7610-7615.
15. Gamet-Payrastre,L., Li,P., Lumeau,S., Cassar,G., Dupont,M.A., Chevolleau,S., Gasc,N., Tulliez,J. and Terce,F. (2000) Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res., 60, 1426-1433.
16. Fimognari,C., Nüsse,M., Cesari,R., Iori,R., Cantelli-Forti,G.and Hrelia,P. (2002) Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis, 23, 581-586.
17. Misiewicz,I., Skupinska,K. and Kasprzycka-Guttman,T. (2003) Sulforaphane and 2-oxohexyl isothiocyanate induce cell growth arrest and apoptosis in L-1210 leukemia and ME-18 melanoma cells. Oncol. Rep., 10, 2045-2050.
18. Wang,L., Liu,D., Ahmed,T., Chung,F.L., Conaway,C.C. and Chiao,J.W. (2004) Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int. J. Oncol., 24, 187-192.
19. Jackson,S.J.T. and Singletary,K.W. (2004) Sulforaphane: A naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis, 25, 219-227.
20. Singh,A.V., Xiao,D., Lew,K.L., Dhir,R. and Singh,S.V. (2004) Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis, 25, 83-90.
21. 2/M phase cell cycle arrest involves checkpoint kinase 2 mediated phosphorylation of Cdc25C. J. Biol. Chem., 279, 25813-25822.
22. Choi,S. and Singh,S.V. (2005) Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable derived cancer chemopreventive agent. Cancer Res., 65, 2035-2043.
23. Singh,S.V., SrivastavaS.K., Choi,S. et al. (2005) Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J. Biol. Chem., 280, 19911-19924.
24. Myzak,M.C., Hardin,K., Wang,R., Dashwood,R.H. and Ho,E. (2006) Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis, 27, 811-819.
25. Agarwal,M.L., Taylor,W.R., Chernov,M.V., Chernova,O.B. and Stark,G.R. (1998) The p53 network. J. Biol. Chem., 273, 1-4.
26. Sheikh,M.S. and Fornace,A.J. (2000) Role of p53 family members in apoptosis. J. Cell. Physiol., 182, 171-181.
27. Miyashita,T. and Reed,J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
28. Reed,J.C. (1997) Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies. Semin. Hematol., 34, 9-19.
29. Chao,D.T. and Korsmeyer,S.J. (1998) Bcl-2 family: Regulators of cell death. Annu. Rev. Immunol., 16, 395-419.
30. Wei,M.C., Zong,W.X., Cheng,E.H., Lindsten,T., Panoutsakopoulou,V., Ross,A.J., Roth,K.A., MacGregor,G.R., Thompson,C.B. and Korsmeyer,S.J. (2001) Proapoptotic Bax and Bak: A requisite gateway to mitochondrial dysfunction and death. Science, 292, 727-730.
31. Wolter,K.G., Hsu,Y.T., Smith,C.L., Nechushtan,A., Xi,X.G. and Youle,R.J. (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol., 139, 1281-1292.
32. Yamaguchi,H. and Wang,H.G. (2001) The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene, 20, 7779-7786.
33. LaCasse,E.C., Baird,S., Korneluk,R.G. and MacKenzie,A.E. (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene, 17, 3247-3259.
34. Deveraux,Q.L. and Reed,J.C. (1999) IAP family proteins-suppressors of apoptosis. Genes Dev., 13, 239-252.
35. Cummins,J.M., Kohli,M., Rago,C., Kinzler,K.W., Vogelstein,B. and Bunz,F. (2004) X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res., 64, 3006-3008.
36. Chu,Z.L., McKinsey,T.A., Liu,L., Gentry,J.J., Malim,M.H. and Ballard,D.W. (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc. Natl Acad. Sci. USA, 94, 10057-10062.
37. You,M., Ku,P.T., Hrdlickova,R. and Bose,H.R. (1997) ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the anti-apoptotic activity of the v-Rel oncoprotein. Mol. Cell. Biol., 17, 7328-7341.
38. Stehlik,C., de Martin,R., Kumabashiri,I., Schmid,J.A., Binder,B.R. and Lipp,J. (1998) Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med., 188, 211-216.
39. Bargou,R.C., Emmerich,F., Krappmann,D. et al. (1997) Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest., 100, 2961-2969.
40. Shattuck-Brandt,R.L. and Richmond,A. (1997) Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells. Cancer Res., 57, 3032-3039.
41. Palayoor,S.T., Youmell,M.Y., Calderwood,S.K., Coleman,C.N. and Price,B.D. (1999) Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene, 18, 7389-7394.
42. Xu,C., Shen,G., Chen,C., Gelinas,C. and Kong,A.N. (2005) Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Oncogene, 24, 4486-4495.
43. Cecconi,F., Alvarez-Bolado,G., Meyer,B.I., Roth,K.A. and Gruss,P. (1998) Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell, 94, 727-737.
44. Yoshida,H., Kong,Y., Yoshida,R., Elia,A.J., Hakem,A., Hakem,R., Penninger,J.M. and Mak,T.W. (1998) Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell, 94, 739-750.
45. Soengas,M.S., Alarcón,R.M., Yoshida,H., Giaccia,A.J., Hakem,R., Mak,T.W. and Lowe,S.W. (1999) Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science, 284, 156-159.
46. Moroni,M.C., Hickman,E.S., Lazzerini-Denchi,E., Caprara,G., Colli,E., Cecconi,F., Müller,H. and Helin,K. (2001) Apaf-1 is a transcriptional target for E2F and p53. Nature Cell Biol., 3, 552-558.
47. Wang,W., Dong,L., Saville,B. and Safe,S. (1999) Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol. Endocrinol., 13, 1373-1387.
48. Stevens,C., Smith,L. and La Thangue,N.B. (2003) Chk2 activates E2F-1 in response to DNA damage. Nature Cell Biol, 5, 401-409.
49. Yang,J., Yu,Y., Hamrick,H.E. and Duerksen-Hughes,P.J. (2003) ATM, ATR and DNA-PK: Initiators of the cellular genotoxic stress response. Carcinogenesis, 24, 1571-1580.
50. Oltvai,Z.N., Milliman,C.L. and Korsmeyer,S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell, 74, 609-619.
51. Kiefer,M.C., Brauer,M.J., Powers,V.C., Wu,J.J., Umansky,S.R., Tomei,L.D. and Barr,P.J. (1995) Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature, 374, 736-739.
52. Bhalla,K.N. (2003) Microtubule-targeted anticancer agents and apoptosis. Oncogene, 22, 9075-9086.